A Elbaz

Summary

Country: France

Publications

  1. doi [Parkinson's disease: Is there a strong environmental contribution?]
    A Elbaz
    INSERM, Unité 708, Service de Neuroépidémiologie, Hopital de la Salpetriere, 47 Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Neurol (Paris) 166:757-63. 2010
  2. pmc Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study
    Julien Dumurgier
    INSERM, U708, F 75013, Paris, France
    BMJ 339:b4460. 2009
  3. pmc Association of walking speed in late midlife with mortality: results from the Whitehall II cohort study
    Alexis Elbaz
    INSERM, U708, Neuroepidemiology, 75013, Paris, France
    Age (Dordr) 35:943-52. 2013
  4. pmc Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
    Alexis Elbaz
    INSERM, U708, Neuroepidemiology, F 75013, Paris, France
    Ann Neurol 69:778-92. 2011
  5. doi Professional exposure to pesticides and Parkinson disease
    Alexis Elbaz
    INSERM, U, Paris, France
    Ann Neurol 66:494-504. 2009
  6. ncbi Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group
    A Elbaz
    INSERM U 360, Recherches Epidemiologiques en Neurologie et Psychopathologie, Hopital de la Salpetriere, Paris, France
    Neurology 52:1876-82. 1999
  7. ncbi Parkinson's disease, smoking, and family history. EUROPARKINSON Study Group
    A Elbaz
    INSERM U 360, Recherches Epidemiologiques en Neurologie et Psychopathologie, H pital de la Salpêtrière, Paris, France
    J Neurol 247:793-8. 2000
  8. ncbi Genetic susceptibility and ischaemic stroke
    A Elbaz
    INSERM Unité 360, Hopital de la Salpetriere, Paris, France
    Curr Opin Neurol 12:47-55. 1999
  9. ncbi Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases
    G Hetet
    INSERM U409 and Association Claude Bernard, Paris, France, Salpetriere Hospital, Paris, France
    Eur J Clin Invest 31:382-8. 2001
  10. doi Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
    M Anheim
    INSERM, U975, Paris, France
    Neurology 78:417-20. 2012

Detail Information

Publications11

  1. doi [Parkinson's disease: Is there a strong environmental contribution?]
    A Elbaz
    INSERM, Unité 708, Service de Neuroépidémiologie, Hopital de la Salpetriere, 47 Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Rev Neurol (Paris) 166:757-63. 2010
    ..In this review, we will present current evidence by focusing on specific illustrative examples...
  2. pmc Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study
    Julien Dumurgier
    INSERM, U708, F 75013, Paris, France
    BMJ 339:b4460. 2009
    ..To study the relation between low walking speed and the risk of death in older people, both overall and with regard to the main causes of death...
  3. pmc Association of walking speed in late midlife with mortality: results from the Whitehall II cohort study
    Alexis Elbaz
    INSERM, U708, Neuroepidemiology, 75013, Paris, France
    Age (Dordr) 35:943-52. 2013
    ..39, 95% CI = 1.04-1.84). In conclusion, walking speed measured in late midlife seems to be an important marker of mortality risk; multiple factors, in particular inflammatory markers, partially explain this association...
  4. pmc Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
    Alexis Elbaz
    INSERM, U708, Neuroepidemiology, F 75013, Paris, France
    Ann Neurol 69:778-92. 2011
    ....
  5. doi Professional exposure to pesticides and Parkinson disease
    Alexis Elbaz
    INSERM, U, Paris, France
    Ann Neurol 66:494-504. 2009
    ..Our objective was to investigate the role of specific pesticide families and to perform dose-effect analyses...
  6. ncbi Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group
    A Elbaz
    INSERM U 360, Recherches Epidemiologiques en Neurologie et Psychopathologie, Hopital de la Salpetriere, Paris, France
    Neurology 52:1876-82. 1999
    ..To investigate the familial aggregation of PD in a large collaborative population-based case-control study...
  7. ncbi Parkinson's disease, smoking, and family history. EUROPARKINSON Study Group
    A Elbaz
    INSERM U 360, Recherches Epidemiologiques en Neurologie et Psychopathologie, H pital de la Salpêtrière, Paris, France
    J Neurol 247:793-8. 2000
    ..In conclusion, our findings suggest that smoking and family history interact synergistically on a multiplicative scale in determining the risk of PD in individuals older than 75 years...
  8. ncbi Genetic susceptibility and ischaemic stroke
    A Elbaz
    INSERM Unité 360, Hopital de la Salpetriere, Paris, France
    Curr Opin Neurol 12:47-55. 1999
    ..This may have therapeutic and preventive implications...
  9. ncbi Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases
    G Hetet
    INSERM U409 and Association Claude Bernard, Paris, France, Salpetriere Hospital, Paris, France
    Eur J Clin Invest 31:382-8. 2001
    ..Positive association studies have been recently published between cardiovascular diseases and heterozygosity for the major mutation C282Y in the haemochromatosis gene HFE...
  10. doi Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
    M Anheim
    INSERM, U975, Paris, France
    Neurology 78:417-20. 2012
    ..Our objective was to estimate PD penetrance in a familial study of GBA mutation carriers...
  11. ncbi Common carotid artery intima-media thickness and brain infarction : the Etude du Profil Génétique de l'Infarctus Cérébral (GENIC) case-control study. The GENIC Investigators
    P J Touboul
    Department of Neurology, Lariboisiere Hospital, Paris, France
    Circulation 102:313-8. 2000
    ..73; 95% confidence interval, 1.45 to 2.07). CONCLUSIONS-An increased CCA-IMT was associated with BI, both overall and in the main subtypes. An increased IMT may help select patients at high risk for BI...